71 related articles for article (PubMed ID: 9255912)
1. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years.
Zenz W; Arlt F; Sodia S; Berghold A
Semin Thromb Hemost; 1997; 23(3):321-32. PubMed ID: 9255912
[TBL] [Abstract][Full Text] [Related]
2. Perinatal risk factors for neonatal intracerebral hemorrhage in preterm infants.
Ertan AK; Tanriverdi HA; Meier M; Schmidt W
Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):29-34. PubMed ID: 16815469
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
Al-Khawaja D; Eslick GD; Fuller SJ; Seex K
J Clin Neurosci; 2007 Sep; 14(9):898-900. PubMed ID: 17660059
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis in newborns and infants.
Nowak-Göttl U; Auberger K; Halimeh S; Junker R; Klinge J; Kreuz WD; Ries M; Schlegel N
Thromb Haemost; 1999 Sep; 82 Suppl 1():112-6. PubMed ID: 10695499
[TBL] [Abstract][Full Text] [Related]
5. An experimental model of intracranial hemorrhage during thrombolytic therapy with t-PA.
Paoni NF; Steinmetz HG; Gillett N; Refino CJ; Badillo JM; Bunting S
Thromb Haemost; 1996 May; 75(5):820-6. PubMed ID: 8725730
[TBL] [Abstract][Full Text] [Related]
6. Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project.
Huynh T; Cox JL; Massel D; Davies C; Hilbe J; Warnica W; Daly PA;
Am Heart J; 2004 Jul; 148(1):86-91. PubMed ID: 15215796
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors for intracerebral hemorrhage after intravenous thrombolysis in acute cerebral infarction].
Li D; Lei YN
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Oct; 15(10):631-3. PubMed ID: 14552692
[TBL] [Abstract][Full Text] [Related]
8. [Intracranial hemorrhage following thrombolytic therapy in acute myocardial infarct].
Torres Martínez G; Rodríguez García P; Cantón Martínez A; Castillo Soria F; Galcerá Tomás J; García Paredes T; Bru Cartagena M; Jara Pérez P
Rev Esp Cardiol; 1994 Feb; 47(2):73-80. PubMed ID: 8165351
[TBL] [Abstract][Full Text] [Related]
9. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
10. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
[TBL] [Abstract][Full Text] [Related]
11. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
12. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
Kimura K; Iguchi Y; Shibazaki K; Kobayashi K; Uemura J; Aoki J; Yamashita S; Terasawa Y; Matsumoto N
J Neurol Sci; 2008 Jul; 270(1-2):48-52. PubMed ID: 18304581
[TBL] [Abstract][Full Text] [Related]
13. Types, causes, and outcome of intracranial hemorrhage in children with cancer.
Kyrnetskiy EE; Kun LE; Boop FA; Sanford RA; Khan RB
J Neurosurg; 2005 Jan; 102(1 Suppl):31-5. PubMed ID: 16206731
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for intracranial hemorrhage in the extracorporeal membrane oxygenation patient.
Dela Cruz TV; Stewart DL; Winston SJ; Weatherman KS; Phelps JL; Mendoza JC
J Perinatol; 1997; 17(1):18-23. PubMed ID: 9069059
[TBL] [Abstract][Full Text] [Related]
15. Intracranial hemorrhage in children: an evolving spectrum.
Lo WD; Lee J; Rusin J; Perkins E; Roach ES
Arch Neurol; 2008 Dec; 65(12):1629-33. PubMed ID: 19064750
[TBL] [Abstract][Full Text] [Related]
16. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.
Gupta AA; Leaker M; Andrew M; Massicotte P; Liu L; Benson LN; McCrindle BW
J Pediatr; 2001 Nov; 139(5):682-8. PubMed ID: 11713447
[TBL] [Abstract][Full Text] [Related]
17. [Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits].
Schaller C; Rohde V; Hassler W
Nervenarzt; 1995 Apr; 66(4):275-81. PubMed ID: 7783814
[TBL] [Abstract][Full Text] [Related]
18. Intracerebral Hemorrhage-Score Allows a Reliable Prediction of Mortality in Patients with Spontaneous Intracerebral Hemorrhage Managed by Fibrinolytic Therapy.
Malinova V; Iliev B; Mielke D; Rohde V
Cerebrovasc Dis; 2019; 48(3-6):165-170. PubMed ID: 31722333
[TBL] [Abstract][Full Text] [Related]
19. The molecular basis of thrombolysis and its clinical application in stroke.
Murray V; Norrving B; Sandercock PA; Terént A; Wardlaw JM; Wester P
J Intern Med; 2010 Feb; 267(2):191-208. PubMed ID: 20175866
[TBL] [Abstract][Full Text] [Related]
20. New developments in thrombolytic therapy.
Collen D; Gold HK
Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
